Al Avatar Pharma extends credit line with Al-Inma

Avalon Pharma Company, a subsidiary of the Middle East for Pharmaceutical Industries, renewed a credit facilities agreement with Alinma Bank worth 50 million Saudi riyals, for a one-year period starting from August 19, 2026. The purpose of the facility is to support working capital and capital expenditures. The agreement includes a promissory note guarantee for the financing amount and emphasizes transparency and the absence of related parties. This financing reflects the company's strategy to diversify funding sources and support the growth of the pharmaceutical industry sector in line with Saudi Vision 2030.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل